Radiotherapy for Vestibular Schwannoma: Retrospective Cohort and Propensity Score Matching Analysis

Vinicius de Carvalho Gico; Geovanne Pedro Mauro; Leila Maria Da Roz; Eduardo Weltman; Evandro César De Souza; Rosangela Correa Villar; Eberval Gadelha Figueiredo; Carlos Gilberto Carlotti

doi:10.1055/a-2620-0288

Journal of Neurological Surgery Part B: Skull Base, Table of Contents

J Neurol Surg B Skull Base
DOI: 10.1055/a-2620-0288

Original Article

Radiotherapy for Vestibular Schwannoma: Retrospective Cohort and Propensity Score Matching Analysis

Vinicius de Carvalho Gico

¹Department of Radiation Oncology, Instituto do Câncer do Estado de São Paulo, Medical School of Sao Paulo University, Sao Paulo, SP, Brazil

,

Geovanne Pedro Mauro

²Department of Radiology and Oncology—Discipline of Radiotherapy, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

,

Leila Maria Da Roz

³Department of Neurology—Discipline of Neurosurgery, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

,

Eduardo Weltman

²Department of Radiology and Oncology—Discipline of Radiotherapy, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

⁴Department of Radiation Oncology, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil

,

Evandro César De Souza

³Department of Neurology—Discipline of Neurosurgery, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

,

Rosangela Correa Villar

²Department of Radiology and Oncology—Discipline of Radiotherapy, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

,

Eberval Gadelha Figueiredo

³Department of Neurology—Discipline of Neurosurgery, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

,

Carlos Gilberto Carlotti

³Department of Neurology—Discipline of Neurosurgery, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, Brazil

› Author Affiliations

Abstract

Background

Surgery and stereotactic radiotherapy (SRT) are widely used for treating vestibular schwannomas (VS), but the impact of different SRT regimens remains debated. This study assesses outcomes of various SRT techniques in a large cohort.

Materials and Methods

Retrospective cohort of consecutive patients treated in a large academic hospital between 2008 and 2024. All patients were treated with LINAC-based SRT. The study compared outcomes between single-dose SRS (12–15 Gy), five-fraction SRS (total of 25 Gy), and conventionally fractionated SRT (50.4 Gy in 28 fractions). The main outcome was progression-free survival (PFS).

Results

The cohort included 197 patients, with a median age of 50.2 years, 65.5% of whom were female. The mean lesion size was 2.4 cm, and 61.4% of lesions were classified as high-class Koos (III and IV). Median follow-up was 54.0 months (6–142.1). Overall lesion control was 89.8% by RECIST 1.1 criteria, with no significant difference in PFS between the groups after propensity score matching. New hearing loss occurred in 14.7% of patients, whereas new facial palsy was reported in 3.0%. The presence of type-2 neurofibromatosis (NF2) was associated with poorer PFS (50.4 vs. 46.6 months, p = 0.002). Propensity score matching analysis was done and all regimens had similar PFS (matched sample size was 193, p = 0.808).

Conclusion

Different SRT regimens showed similar outcomes for lesion control and toxicity in VS patients, including those with NF2. This study supports LINAC-based SRT as a flexible treatment option, although further prospective studies are needed.

Keywords

schwannoma - radiosurgery - radiotherapy - stereotactic

Full Text

References

References
1 Sarmiento JM, Patel S, Mukherjee D, Patil CG. Improving outcomes in patients with vestibular schwannomas: microsurgery versus radiosurgery. J Neurosurg Sci 2013; 57 (01) 23-44
2 Brun L, Mom T, Guillemin F, Puechmaille M, Khalil T, Biau J. The recent management of vestibular schwannoma radiotherapy: a narrative review of the literature. J Clin Med 2024; 13 (06) 1611
3 Jakubeit T, Sturtz S, Sow D. et al. Single-fraction stereotactic radiosurgery versus microsurgical resection for the treatment of vestibular schwannoma: a systematic review and meta-analysis. Syst Rev 2022; 11 (01) 265
4 Thai NLB, Mai NY, Vuong NL. et al. Treatment for vestibular schwannoma: systematic review and single arm meta-analysis. Am J Otolaryngol 2022; 43 (02) 103337
5 Tsao MN, Sahgal A, Xu W. et al. Stereotactic radiosurgery for vestibular schwannoma: International Stereotactic Radiosurgery Society (ISRS) practice guideline. J Radiosurg SBRT 2017; 5 (01) 5-24
6 Goldbrunner R, Weller M, Regis J. et al. EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro-oncol 2020; 22 (01) 31-45
7 Prescribing R, Intensity-Modulated RP-B. Radiation therapy (IMRT). J ICRU 2010; 10 (01) 97-99
8 Delsanti C, Roche PH, Thomassin JM, Régis J. 2008. Morphological changes of vestibular schwannomas after radiosurgical treatment: pitfalls and diagnosis of failure. In: Modern Management of Acoustic Neuroma (Vol. 21, pp. 93–97). Karger Publishers;
9 De Leo AN, Shah A, Li J. et al. Stereotactic radiosurgery for vestibular schwannoma with radiographic brainstem compression. Am J Clin Oncol 2024; 47 (03) 110-114
10 Lefranc M, Da Roz LM, Balossier A, Thomassin JM, Roche PH, Regis J. Place of gamma knife stereotactic radiosurgery in grade 4 vestibular schwannoma based on case series of 86 patients with long-term follow-up. World Neurosurg 2018; 114: e1192-e1198
11 Conlan O, Kontorinis G. Long-term growth patterns of vestibular schwannomas after stereotactic radiotherapy: delayed re-growth. Eur Arch Otorhinolaryngol 2022; 279 (10) 4825-4830
12 Dhayalan D, Tveiten ØV, Finnkirk M. et al; V-REX Trial investigators. Upfront radiosurgery vs a wait-and-scan approach for small-or medium-sized vestibular schwannoma: the V-REX randomized clinical trial. JAMA 2023; 330 (05) 421-431
13 Fouad A, Tran ED, Feng AY. et al. Stereotactic radiosurgery for vestibular schwannoma outcomes in patients with perfect word recognition-a retrospective cohort study. Otol Neurotol 2021; 42 (05) 755-764
14 Balossier A, Tuleasca C, Delsanti C. et al. Long-term hearing outcome after radiosurgery for vestibular schwannoma: a systematic review and meta-analysis. Neurosurgery 2023; 92 (06) 1130-1141
15 Kang H, Ji SY, Kim CY. et al. Hearing preservation after stereotactic radiosurgery for sporadic intracanalicular vestibular schwannomas classified as Koos grade 1. Cancer Med 2024; 13 (02) e6990
16 van Linge A, van Os R, Hoekstra N. et al. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level. Radiat Oncol 2018; 13 (01) 253
17 Chang SD, Muacevic A, Klein AL. et al. Impact of cochlear dose on hearing preservation following stereotactic radiosurgery in treatment of vestibular schwannomas: a multi-center study. World Neurosurg 2023; 178: e24-e33
18 Tuleasca C, Toma-Dasu I, Duroux S. et al. Impact of the mean cochlear biologically effective dose on hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a retrospective longitudinal analysis. Neurosurgery 2024; 94 (01) 174-182
19 Milano MT, Grimm J, Niemierko A. et al. Single-and multifraction stereotactic radiosurgery dose/volume tolerances of the brain. Int J Radiat Oncol Biol Phys 2021; 110 (01) 68-86
20 Tuleasca C, Toma-Dasu I, Duroux S. et al. The relevance of biologically effective dose for hearing preservation after stereotactic radiosurgery for vestibular schwannomas: a retrospective longitudinal study. Neurosurgery 2023; 92 (06) 1216-1226
21 Khong J, Govindaraj R, Ramm D, Edwards S, Roos D. Cochlear sparing in LINAC-based radiosurgery for vestibular schwannoma: a dosimetric comparison of dynamic conformal arc, IMRT and VMAT treatment plans. Radiat Oncol 2023; 18 (01) 2
22 Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 2010; 76 (01) 193-200
23 Collen C, Ampe B, Gevaert T. et al. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. Int J Radiat Oncol Biol Phys 2011; 81 (04) e503-e509
24 Andrews DW, Suarez O, Goldman HW. et al. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 2001; 50 (05) 1265-1278
25 Régis J, Pellet W, Delsanti C. et al. Functional outcome after gamma knife surgery or microsurgery for vestibular schwannomas. J Neurosurg 2002; 97 (05) 1091-1100
26 Wang SSY, Horstmann G, van Eck A, Tatagiba M, Naros G. Likelihood-of-harm/help of microsurgery compared to radiosurgery in large vestibular schwannoma. J Neurooncol 2024; 169 (02) 299-308
27 Hildrew DM, Perez PL, Mady LJ, Li J, Nilsen ML, Hirsch BE. CyberKnife stereotactic radiosurgery for growing vestibular schwannoma: longitudinal tumor control, hearing outcomes, and predicting post-treatment hearing status. Laryngoscope 2024; 134 (Suppl. 01) S1-S12
28 Maria S. Long-term hearing outcomes following stereotactic radiosurgery in vestibular schwannoma patients-a retrospective cohort study (vol 85, pg 550, 2019). Neurosurgery 2020; 87 (04) 857-857
29 Puataweepong P, Dhanachai M, Swangsilpa T. et al. Long-term clinical outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy using the CyberKnife robotic radiosurgery system for vestibular schwannoma. Asia Pac J Clin Oncol 2022; 18 (05) e247-e254
30 de Jel DVC, Smid EJ, van Doormaal TPC, Thomeer HGXM. Hearing outcome after linear accelerator-based radiotherapy for vestibular schwannomas: a retrospective analysis of a single center. J Int Adv Otol 2021; 17 (05) 426-432
31 Tatagiba M, Wang SS, Rizk A. et al. A comparative study of microsurgery and gamma knife radiosurgery in vestibular schwannoma evaluating tumor control and functional outcome. Neurooncol Adv 2023; 5 (01) vdad146
32 Daloiso A, Cazzador D, Concheri S, Tealdo G, Zanoletti E. Long-term hearing outcome for vestibular schwannomas after microsurgery and radiotherapy: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2024; 171 (06) 1670-1681
33 Tuleasca C, Kotecha R, Sahgal A. et al. Single-fraction radiosurgery outcomes for large vestibular schwannomas in the upfront or post-surgical setting: a systematic review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines. J Neurooncol 2023; 165 (01) 1-20
34 Pikis S, Mantziaris G, Kormath Anand R. et al. Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a multi-institutional study. J Neurosurg 2022; 138 (02) 405-412
35 Sharma M, Papisetty S, Dhawan S, Ahluwalia MS, Venteicher AS, Chen CC. Comparison of stereotactic radiosurgery and hypofractionated radiosurgery for vestibular schwannomas: a meta-analysis of available literature. World Neurosurg 2024; 182: e742-e754
36 Tosi U, Guadix S, An A. et al. Efficacy and comorbidities of hypofractionated and single-dose radiosurgery for vestibular schwannomas: a systematic review and meta-analysis. Neurooncol Pract 2021; 8 (04) 391-404
37 Gawish A, Walke M, Röllich B, Ochel HJ, Brunner TB. Vestibular schwannoma hypofractionated stereotactic radiation therapy in five fractions. Clin Oncol (R Coll Radiol) 2023; 35 (01) e40-e47
38 Söderlund Diaz L, Hallqvist A. LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution. J Neurooncol 2020; 147 (02) 351-359
39 Küchler M, El Shafie RA, Adeberg S. et al. Outcome after radiotherapy for vestibular schwannomas (VS)-differences in tumor control, symptoms and quality of life after radiotherapy with photon versus proton therapy. Cancers (Basel) 2022; 14 (08) 1916
40 Udawatta M, Kwan I, Preet K. et al. Hearing preservation for vestibular schwannomas treated with stereotactic radiosurgery or fractionated stereotactic radiotherapy. World Neurosurg 2019; 129: e303-e310
41 Patel KS, Ng E, Kaur T. et al. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma. J Neurooncol 2019; 145 (02) 329-337
42 Santa Maria PL, Shi Y, Aaron KA. et al. Tumor control following stereotactic radiosurgery in patients with vestibular schwannomas - a retrospective cohort study. Otol Neurotol 2021; 42 (10) e1548-e1559
43 Shrivastava M, Emmanouil B, Mathew R. et al. Stereotactic radiosurgery and radiotherapy for vestibular schwannoma in NF2-related schwannomatosis. Laryngoscope 2024; 134 (05) 2364-2371
44 Mauro GP, Da Róz LM, Gico VC. et al. Fractionated stereotactic radiotherapy compared to stereotactic radiosurgery for vestibular schwannoma in patients with type 2 neurofibromatosis. World Neurosurg 2023; 179: e416-e420